留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

健康公平性在指南制订中的思考与方法学建议

高一城 刘芷含 陶立元 曹蕊 夏如玉 冯玉婷 方锐 邓迎杰 向文远 费宇彤

高一城, 刘芷含, 陶立元, 曹蕊, 夏如玉, 冯玉婷, 方锐, 邓迎杰, 向文远, 费宇彤. 健康公平性在指南制订中的思考与方法学建议[J]. 协和医学杂志, 2023, 14(6): 1319-1324. doi: 10.12290/xhyxzz.2023-0096
引用本文: 高一城, 刘芷含, 陶立元, 曹蕊, 夏如玉, 冯玉婷, 方锐, 邓迎杰, 向文远, 费宇彤. 健康公平性在指南制订中的思考与方法学建议[J]. 协和医学杂志, 2023, 14(6): 1319-1324. doi: 10.12290/xhyxzz.2023-0096
GAO Yicheng, LIU Zhihan, TAO Liyuan, CAO Rui, XIA Ruyu, FENG Yuting, FANG Rui, DENG Yingjie, XIANG Wenyuan, FEI Yutong. Considerations and Methodological Suggestions on Health Equity in Clinical Practice Guideline Development[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1319-1324. doi: 10.12290/xhyxzz.2023-0096
Citation: GAO Yicheng, LIU Zhihan, TAO Liyuan, CAO Rui, XIA Ruyu, FENG Yuting, FANG Rui, DENG Yingjie, XIANG Wenyuan, FEI Yutong. Considerations and Methodological Suggestions on Health Equity in Clinical Practice Guideline Development[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1319-1324. doi: 10.12290/xhyxzz.2023-0096

健康公平性在指南制订中的思考与方法学建议

doi: 10.12290/xhyxzz.2023-0096
基金项目: 

新疆维吾尔自治区重点研发计划 2021B03006-4

详细信息
    通讯作者:

    FEI Yutong, E-mail: yutong_fei@163.com

  • 中图分类号: R181.2

Considerations and Methodological Suggestions on Health Equity in Clinical Practice Guideline Development

Funds: 

Key Research and Development Program of Xinjiang Uygur Autonomous Region 2021B03006-4

  • 摘要: 健康公平性能够缩小不同群体之间的健康差异, 使公民享有公平的健康服务。目前, 指南制订者越来越重视对健康公平性的考虑, 并在指南制订的过程中进行了初步探索和应用。但现有指南制订过程对于健康公平性的结构化和系统化构建考虑较少, 其对未来指南制订的指导较有限。本文探讨在指南制订关键环节对健康公平性系统化构建进行深入思考的方法学建议, 以期为指南制订者提供参考。
    作者贡献:高一城负责查阅资料、撰写论文;刘芷含、陶立元、曹蕊、夏如玉、冯玉婷、方锐、邓迎杰、向文远负责补充资料、修订论文;费宇彤负责论文结构设计、指导写作及审校。
    利益冲突:所有作者均声明不存在利益冲突
  • [1] Braveman P, Gruskin S. Defining equity in health[J]. J Epidemiol Community Health, 2003, 57: 254-258. doi:  10.1136/jech.57.4.254
    [2] Whitehead M. The concepts and principles of equity and health[J]. Int J Health Serv, 1992, 22: 429-445. doi:  10.2190/986L-LHQ6-2VTE-YRRN
    [3] World Health Organization. WHO handbook for guideline development (2nd edition). [EB/OL]. (2014-12-18)[2023-01-28]. https://www.who.int/publications/i/item/9789241548960.
    [4] National Institute for Health and Care Excellence. Developing Nice Guidelines the Manual[EB/OL]. (2020-10-05)[2023-01-22]. https://www.nice.org.uk/process/pmg20/chapter/introduction.
    [5] Scottish Intercollegiate Guidelines Network. A guideline developer's handbook[EB/OL]. (2019-11)[2023-01-22]. http://www.sign.ac.uk/.
    [6] Schünemann HJ, Wiercioch W, Etxeandia I, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise[J]. CMAJ, 2014, 186: E123-E142. doi:  10.1503/cmaj.131237
    [7] Chen Y, Yang K, Marušic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement[J]. Ann Intern Med, 2017, 166: 128-132. doi:  10.7326/M16-1565
    [8] Policy brief by the HLCP Inequalities Task Team. Tackling inequalities in public service coverage to "build forward better" for the rural poor. [EB/OL]. (2021-12-17)[2023-01-22]. https://www.who.int/publications/m/item/tackl-ing-inequalities-in-public-service-coverage-to-build-forward-better-for-the-rural-poor.
    [9] National Center for Health Statistics. Healthy People 2020 Progress by Population Group[EB/OL]. (2020-12-14)[2023-01-22]. https://www.cdc.gov/nchs/healthy_people/hp2020-final-review.htm.
    [10] Marmot M, Commission on Social Determinants of Health. Achieving health equity: from root causes to fair outcomes[J]. Lancet, 2007, 370: 1153-1163. doi:  10.1016/S0140-6736(07)61385-3
    [11] Tarlov A. Social Determinants of Health: the sociobiological ranslation[M]. London: Routledge, 1996.
    [12] O'Neill J, Tabish H, Welch V, et al. Applying an equity lens to interventions: using PROGRESS ensures considera-tion of socially stratifying factors to illuminate inequities in health[J]. J Clin Epidemiol, 2014, 67: 56-64. doi:  10.1016/j.jclinepi.2013.08.005
    [13] Oliver S, Kavanagh J, Caird J, et al. Health promotion, inequalities and young people's health. A systematic review of research[EB/OL]. (2008-10)[2023-03-29]. https://discovery.ucl.ac.uk/id/eprint/10018803/.
    [14] Oliver S, Dickson K, Gough D, et al. An introduction to systematic reviews[M]. London: SAGE Publications, 2012.
    [15] Alonso-Coello P, Schünemann HJ, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction[J]. BMJ, 2016, 353: i2016.
    [16] Welch VA, Akl EA, Guyatt G, et al. GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale[J]. J Clin Epidemiol, 2017, 90: 59-67. doi:  10.1016/j.jclinepi.2017.01.014
    [17] Akl EA, Welch V, Pottie K, et al. GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklist[J]. J Clin Epidemiol, 2017, 90: 68-75. doi:  10.1016/j.jclinepi.2017.01.017
    [18] Welch VA, Akl EA, Pottie K, et al. GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence[J]. J Clin Epidemiol, 2017, 90: 76-83. doi:  10.1016/j.jclinepi.2017.01.015
    [19] Pottie K, Welch V, Morton R, et al. GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process[J]. J Clin Epidemiol, 2017, 90: 84-91. doi:  10.1016/j.jclinepi.2017.08.001
    [20] Barnabe C, Pianarosa E, Hazlewood G. Informing the GRADE evidence to decision process with health equity considerations: demonstration from the Canadian rheumatoid arthritis care context[J]. J Clin Epidemiol, 2021, 138: 147-155. doi:  10.1016/j.jclinepi.2021.06.013
    [21] Mann RM, Athanasiou A, Baltzer PAT, et al. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)[J]. Eur Radiol, 2022, 32: 4036-4045. doi:  10.1007/s00330-022-08617-6
    [22] Saur NM, Davis BR, Montroni I, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Perioperative Evaluation and Management of Frailty Among Older Adults Undergoing Colorectal Surgery[J]. Dis Colon Rectum, 2022, 65: 473-488. doi:  10.1097/DCR.0000000000002410
    [23] 中华医学会糖尿病学分会, 国家基层糖尿病防治管理办公室. 国家基层糖尿病防治管理指南(2018)[J]. 中华内科杂志, 2018, 57: 885-893. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202224017.htm
    [24] Goodman SM, Springer B, Guyatt G, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty[J]. J Arthroplasty, 2017, 32: 2628-2638. doi:  10.1016/j.arth.2017.05.001
    [25] Palda VA, Davis D, Goldman J. A guide to the Canadian Medical Association Handbook on Clinical Practice Guide-lines[J]. CMAJ, 2007, 177: 1221-1226. doi:  10.1503/cmaj.070880
    [26] Harris JS, Weiss MS, Haas NS, et al. Methodology for ACOEM's Occupational Medicine Practice Guidelines-2017 Revision[J]. J Occup Environ Med, 2017, 59: 913-919. doi:  10.1097/JOM.0000000000001109
    [27] Chung SA, Gorelik M, Langford CA, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa[J]. Arthritis Care Res (Hoboken), 2021, 73: 1061-1070. doi:  10.1002/acr.24633
    [28] 高建民, 杨金娟. 健康公平性概述[J]. 卫生经济研究, 2014(10): 51-54. doi:  10.14055/j.cnki.33-1056/f.2014.10.012
    [29] Groff ML, Offringa M, Emdin A, et al. Publication trends of pediatric and adult randomized controlled trials in general medical journals, 2005-2018: a citation analysis[J]. Children (Basel), 2020, 7: 293.
    [30] National Institutes of Health. NIH Policy and Guidelines on the Inclusion of Children as Participants in Research involving Human Subjects[EB/OL]. (2015-10-13) [2023-01-20]. https://grants.nih.gov/grants/guide/notice-files/not98-024.html.
    [31] Neumann I, Izcovich A, Aguilar R, et al. ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America[J]. Blood Adv, 2021, 5: 3032-3046. doi:  10.1182/bloodadvances.2021004267
    [32] Coronado G, Chio-Lauri J, Cruz RD, et al. Health Disparities of Cardiometabolic Disorders Among Filipino Americans: Implications for Health Equity and Community-Based Genetic Research[J]. J Racial Ethn Health Disparities, 2022, 9: 2560-2567. doi:  10.1007/s40615-021-01190-6
    [33] Welch V, Petticrew M, Tugwell P, et al. PRISMA-Equity Bellagio group. PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity[J]. PLoS Med, 2012, 9: e1001333. doi:  10.1371/journal.pmed.1001333
    [34] Ogilvie D, Egan M, Hamilton V, et al. Systematic reviews of health effects of social interventions: 2. Best available evidence: how low should you go?[J]. J Epidemiol Community Health, 2005, 59: 886-892. doi:  10.1136/jech.2005.034199
    [35] Kanter J, Liem RI, Bernaudin F, et al. American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation[J]. Blood Adv, 2021, 5: 3668-3689. doi:  10.1182/bloodadvances.2021004394C
    [36] Al-Hameed F, Al-Dorzi HM, AlMomen A, et al. Prophyl-axis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline[J]. Ann Saudi Med, 2015, 35: 95-106. doi:  10.5144/0256-4947.2015.95
    [37] Shekelle PG. Clinical Practice Guidelines: What's Next?[J]. JAMA, 2018, 320: 757-758. doi:  10.1001/jama.2018.9660
    [38] Domecq JP, Prutsky G, Elraiyah T, et al. Patient engagement in research: a systematic review[J]. BMC Health Serv Res, 2014, 14: 89. doi:  10.1186/1472-6963-14-89
  • 加载中
计量
  • 文章访问数:  115
  • HTML全文浏览量:  30
  • PDF下载量:  37
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-02-24
  • 录用日期:  2023-04-14
  • 网络出版日期:  2023-05-10
  • 刊出日期:  2023-11-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!